Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2003
08/27/2003CN1438234A Potato 1-amino-cyclopropane-1-carboxylic-synthesized zyme gene chip and primer
08/27/2003CN1438233A Tomato 1-amino-cyclopropane-1-carboxylic-synthesized zyme gene chip and primer
08/27/2003CN1438232A Maize alcohol soluble protein gene chip and primer
08/27/2003CN1438231A Soybean 1-amino-cyclopropane-1-carboxylic-synthesized zyme gene chip and primer
08/27/2003CN1438230A Nucleotide
08/27/2003CN1438229A nucleotide and its use
08/27/2003CN1437957A Method for producing whole silkworm powder milk-containing and ferritin
08/27/2003CN1119422C Virus resistant plants
08/27/2003CN1119421C Recombinant fusion proteins to growth hormone and serum albumin
08/27/2003CN1119420C Secretion-type bacterial strain with chloromycetin resistance to generate glutary-7-aminocephalophytenic acid acylase with high output
08/27/2003CN1119419C Secretion-type bacterial strain to generate glutaryl-7-aminocephalophytenic acid acylase with high output
08/27/2003CN1119418C D-amino acid oxidase of red telioporeae
08/27/2003CN1119417C Primer for cloning thio oxide-reductase gene of high-temp element
08/27/2003CN1119416C Human interleukin 2 derivatives and human heart sodium medium fusion gene, its protein products and uts thereof
08/27/2003CN1119415C Clone and expression of anti-CA125 bifunctional genetically engineered antibody
08/27/2003CN1119414C Mutational 2,5 diketo-D-gluconic acid reductase and its genetic engineering expression
08/27/2003CN1119169C Tumor rejection antigens presented by HLA-B44 molecules, and uses thereof
08/26/2003USRE38240 DNA encoding human endothelial cell growth factors and plasmids comprising said DNA
08/26/2003US6611767 Scanned image alignment systems and methods
08/26/2003US6611766 Quantitative and qualitative analysis of immunologically or pathologically affected cells; two dimensional gel electrophoresis; generating master composite image
08/26/2003US6610986 Soft ionization device and applications thereof
08/26/2003US6610913 Rice plants transformed to provide a PCK-type C4 cycle and methods of making
08/26/2003US6610909 Method for the commercial production of transgenic plants
08/26/2003US6610908 Manipulation of lignin composition in plants using a tissue-specific promoter
08/26/2003US6610907 Cotton leaf curl virus (CLCuV) promoter and its use
08/26/2003US6610906 Nucleotide sequences for gene regulation and methods of use thereof
08/26/2003US6610905 Transgenic mouse model for Kaposi's sarcoma
08/26/2003US6610843 Modified starch from plants, plants synthesizing the same, as well as process for their production
08/26/2003US6610840 Method of isolating a mesophyll-specific promoter
08/26/2003US6610839 Promoter for telomerase reverse transcriptase
08/26/2003US6610834 Human IgM antibodies to chemokine receptors
08/26/2003US6610833 Hybridoma cell line; immunoglobulins; can use in treating human immunodeficiency virus infections
08/26/2003US6610830 Microbial production of mature human leukocyte interferons
08/26/2003US6610829 Human extracellular matrix-1
08/26/2003US6610828 Heliothis ecdysone receptor
08/26/2003US6610820 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
08/26/2003US6610663 Antisense compound with targeting and RNA cleaving moieties, preferably an imidazole functionality conjugated to the targeting oligonucleotide via linkers
08/26/2003US6610661 Immunostimulatory polynucleotide/immunomodulatory molecule conjugates
08/26/2003US6610656 Activating osteogenesis using hedgehog genes or proteins coded by hybridized nucleic acids
08/26/2003US6610650 Modulation of cellular transcription factor activity
08/26/2003US6610545 Nucleotide sequence encoding the enzyme I-SceI and the uses thereof
08/26/2003US6610544 Regeneration of both plant tissues and transgenic plant tissues using a new plant hormone, 5-bromoindole-3-acetic acid
08/26/2003US6610541 Recombinant, active caspases and uses thereof
08/26/2003US6610540 Low oxygen culturing of central nervous system progenitor cells
08/26/2003US6610539 Modulate the expression of the ribonucleotide reductase or the secA genes in microorganisms. This invention is also related to methods of using such oligonucleotides in inhibiting the growth of microorganisms. These antisense oligonucleotides are
08/26/2003US6610537 Human kinases and polynucleotides encoding the same
08/26/2003US6610536 Nucleic acids and polypeptides
08/26/2003US6610534 Induction of blood vessel formation through administration of polynucleotides encoding sphingosine kinases
08/26/2003US6610532 Treating or preventing heart defects in mammals; obtain human, administer modulator, monitor humans for adjustment in heart activity
08/26/2003US6610529 Recombinant bacterial system with environmentally limited viability
08/26/2003US6610527 The taxadiene synthase gene of Pacific yew has been cloned and its nucleic acid and polypeptide sequence is presented. Truncation or removal of the transit peptide increases expression of the cloned taxadiene synthase gene expression in
08/26/2003US6610526 Human E1-like protein
08/26/2003US6610524 Nucleotide sequences coding enzymatic polypeptide for use in cosmetics, pharmacology and food processing
08/26/2003US6610523 Human mitogen-activated (MAP) kinase kinase isoforms (MKKs). MKKs mediate unique signal transduction pathways that activate human MAP kinases p38 and JNK, which result in activation of other factors, including activating
08/26/2003US6610522 Cloned genes encoding reverse transcriptase lacking RNase H activity
08/26/2003US6610521 Isolated nucleic acid fragment encoding a protein involved in phenylpropanoid metabolism. The invention also relates to the construction of a chimeric gene encoding all or a portion of the protein involved in phenylpropanoid metabolism,
08/26/2003US6610520 Gene encoding human manganese superoxide dismutase and recombinant polypeptide encoded thereby
08/26/2003US6610517 Compartmentalization of recombinant polypeptides in host cells
08/26/2003US6610516 A glycoprotein is produced by a process comprising culturing mammalian host cells expressing nucleic acid encoding a glycoprotein in the presence of (a) a factor that modifies growth state in a cell culture, (b) a divalent metal cation or
08/26/2003US6610515 Medicine which promotes the production of neutrophiles in case the number of the neutrophiles decreases upon treating the tumor of a cat, and does not have side-effects, wherein said medicine is prepared by incorporating, as an active
08/26/2003US6610514 Yeast vector and method of producing proteins using the same
08/26/2003US6610513 Receptor proteins
08/26/2003US6610512 Zinc finger binding domains for GNN
08/26/2003US6610511 Drosophila odorant receptors
08/26/2003US6610510 Human Cerberus proteins and related nucleic acids are provided. Included are proteins comprising a human cerberus domain having specific activity, particularly the ability to antagonize a bone morphogenic protein. The proteins may be
08/26/2003US6610508 Translation driver system and methods for use thereof
08/26/2003US6610507 Polynucleotides encoding patched proteins
08/26/2003US6610505 Oncoprotein protein kinase
08/26/2003US6610497 Angiotensin converting enzyme homolog and therapeutic and diagnostic uses therefor
08/26/2003US6610495 Identifying modulators of biological interactions and agents useful for same. More particularly, the present invention contemplates a method of detecting inhibitors of biological interactions involving protein and/or nucleic acid molecules
08/26/2003US6610493 Screening compounds for the ability to alter the production of amyloid-β peptide
08/26/2003US6610492 The present invention is directed to novel base-modified nucleotides and methods for their use in the preparation and cleavage of modified polynucleotides.
08/26/2003US6610489 Pharmacogenomics and identification of drug targets by reconstruction of signal transduction pathways based on sequences of accessible regions
08/26/2003US6610488 Isolation of RNA, DNA and proteins from formalin-fixed paraffin-embedded tissue specimens
08/26/2003US6610486 Detecting nucleotide variation within a first nucleic acid, comprising generating a set of single-stranded extension products from a first nucleic acid in the presence of modified nucleotide bases, wherein the extension products incorporate
08/26/2003US6610485 Kit are provided for selectively isolating genes encoding membrane-bound proteins by fusing proteins to a secretable protein having a binding affinity to an antigen (e.g.an antibody), expressing these fusions in host cells, and
08/26/2003US6610481 Generating preferential nucleotide sequences; obtain nucleic acid mix, incubate with polymerase, amplify sequences, recover preferential sequences
08/26/2003US6610480 Identification of genes which are differentially expressed in hypertrophic cardiac tissue as compared to normal cardiac tissue. Accordingly, the present invention provides nucleotide sequences of genes and promotion or inhibition of the function
08/26/2003US6610478 Phenotypic conversion of cells mediated by external guide sequences
08/26/2003US6610477 Human DNA mismatch repair proteins
08/26/2003US6610475 Kits for processing biological specimens for nucleic acid hybridization assays, target amplification reactions and similar uses
08/26/2003US6610474 Cells for detection of influenza and parainfluenza viruses
08/26/2003US6610473 Peptides for inhibiting HPV E6-proteins
08/26/2003US6610309 Vaccines; mixture of antigen and water solubility organometallic compound
08/26/2003US6610307 Immunity against pasteurella haemolytica leukotoxin
08/26/2003US6610305 Safe attenuated bovine viral diarrhea viruses for use in pregnant cows
08/26/2003US6610303 Papilloma viruses, products for the detection thereof as well as for treating diseases caused by them
08/26/2003US6610301 Immunologically active proteins from Borrelia burgdorferi, nucleic acids which encode them, and their use in test kits and as vaccines
08/26/2003US6610300 Clostridium perfringens vaccine
08/26/2003US6610297 Compositions for treating allergies that include either BSW17 mimotope peptides or antibodies raised against BSW17 mimotope peptides. Also disclosed are methods for the treatment of allergies which involve administration of BSW17 mimeotope
08/26/2003US6610294 Methods of inhibiting an autoimmune response in a human suffering from an autoimmune disease by administering an antibody that binds to a protein to which monoclonal antibody 5C8 binds
08/26/2003US6610293 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
08/26/2003US6610290 Transferring preferential nucleotide sequences to cells; obtain cells, incubate with expression vector, transform cells, recover transformed cells
08/26/2003US6610287 Methods of gene delivery to cells in the nervous system by introducing and expressing gene sequences mediated by herpes simplex virus 1 (HSV-1) vectors with a mutation in a gene for viral replication. Methods for modulating neuronal physiology
08/26/2003US6610285 A full-length cDNA corresponding to an EST (AA418955), which does not show any homology to other proteins in the database but has a weak homology to G-CSF, has been successfully isolated by synthesizing primers based on the EST sequence,
08/26/2003US6610269 Disease state imaged using a targeted contrast agent of the formula V-L-R, where V is a vector moiety having affinity for an angiogenesis-related endothelial cell receptor, L is a linker, R is a macromolecular or particulate label
08/26/2003US6610186 Separating particles or molecules by migration in a separation medium
08/26/2003US6609618 Filtering sample of digested natural sources such as cells or cell fragments using filter the pore size of which decreases in direction of flow of sample through filter
08/26/2003CA2081354C Method of type-specific detection of herpes simplex virus
08/25/2003CA2405347A1 Medicament comprising nk4 gene or recombinant nk4 protein
1 ... 2442 2443 2444 2445 2446 2447 2448 2449 2450 2451 2452 2453 2454 2455 2456 2457 2458 2459 2460 2461 2462 ... 4023